Latest filing published 09 Jan 2019 for MPX Bioceutical Corporation, €39k.
This profile gathers the share dealings of Randall Glenn Stafford in MPX Bioceutical Corporation. The record holds 4 filings, all for trades on 4 January 2019.
No open-market sale appears; the market trades are 2 purchases worth €7,733. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 option exercises.
The newest entry dates from 9 January 2019: an option exercise of €39k, in MPX Bioceutical Corporation. The last insider purchase was made public on 9 January 2019, 2,846 days ago. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations